drugset / Trial / NCT02349685

The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori

NCT02349685

RandomizedParallel-groupOpen-labelTreatment

Summary

As increasing the antibiotics resistance, the effectiveness of traditional Helicobacter pylori (H. pylori) therapies has been declined coincidently. In this study, the investigators evaluated the efficacy of H. pylori eradication between a personalized therapy for H. pylori infection based on the results of antibiotics resistance by using H. pylori culture and minimal inhibitory concentration (MIC) and the traditional 2nd rescue regimens, and the investigators analyzed the prevalence of the antibiotic resistance after 1st eradication of H. pylori in the tailored therapy group.

Timeline

Start
2010-01
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 1 g
Subject Metronidazole Small molecule 500 mg
Subject Moxifloxacin Small molecule 400 mg
Subject Tetracycline Unknown 500 mg
Subject tripotassium dicitrate bismuthate Unknown 300 mg
Background Esomeprazole Small molecule